Perspectives - How will the latest clinical studies on subacute and chronic subdural hematoma treatment impact our practice?

Discover the future of treating chronic subdural hematoma with Dr. Adam Arthur, as he discusses the groundbreaking STEM trial at LINNC Paris 2024 with Dr. Miriam Vicente. This pioneering study examines the embolization of the middle meningeal artery as a safer, less invasive alternative to traditional surgical methods. Dr. Arthur shares promising early results, emphasizing the procedure's safety and potential to improve patient outcomes dramatically.

Learn about the broader implications for neurointervention and the prospects for treating various pathologies with these advanced techniques.